Otsuka’s Voyxact stabilised kidney function at two years in Phase III IgAN trial Abigail Beaney Updated Tue, August 4, 2026 at 3:19 PM UTC 3 min read Add Yahoo as a preferred source to see more of our stories on Google. Otsuka gained accelerated approval ... See more
A research study has indicated that researchers should better consider time differences between individual symptom improvement during schizophrenia clinical trials. A paper, published in Lancet Psychiatry00174-4/fulltext?rss=yes), looked at individual par... See more
The UK’s High Court has rejected a challenge to the regulatory approval for a clinical trial that is investigating puberty blockers in teenagers with gender incongruence. The PATHWAYS trial (ISRCTN12491684), which has created a great deal of controversy s... See more
Novo Nordisk’s monoclonal antibody (mAb) designed to reduce the risk of major adverse cardiovascular events (MACE) in patients with atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD) and inflammation has failed to meet the primar... See more
Pfizer seeks label expansion for Litfulo after double Phase III NSV win Abigail Beaney Thu, July 30, 2026 at 4:33 PM UTC 3 min read Add Yahoo as a preferred source to see more of our stories on Google. Pfizer will speak with regulatory authorities about t... See more
